Summary by Moomoo AI
PHARMARON (Peking) New Drug Technology Co., Ltd. announced that a Board of Directors meeting will be held on March 26, 2025 (Wednesday), with the main agenda including the review and approval of the 2024 annual performance report, and to consider the proposal for the distribution of the final dividend. The meeting will be chaired by Dr. Lou Bai-Liang, Chairman of the Board, with attending board members including executive directors, non-executive directors, and independent non-executive directors.